SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DaiS who wrote (9644)6/15/1998 2:13:00 PM
From: VLAD  Read Replies (1) of 23519
 
DaiS,

You are right saying that a rebound will take some time.

I think that even with Viagra in foreign countries, Vivus can carve out a large enough niche to maintain profitability.

The key now is for Vivus to move their butts in the new plant and get into foreign markets.

Vivus is expecting approval in Canada in July.

They will get a $2,000,000.00 milestone payment from Janssen when this occurs. I hope Janssen is ready to market the minute they get approval. If Vivus is smart enough to improve its marketing techniques in the US to get new scripts flowing and we see this materialize this summer, I think we should be OK. It doesn't matter what percentage of the ED market Vivus has so long as it has a big enough percentage to maintain earnings growth.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext